Literature DB >> 10223180

Heterocyclic aromatic amines induce DNA strand breaks and cell transformation.

W Pfau1, F L Martin, K J Cole, S Venitt, D H Phillips, P L Grover, H Marquardt.   

Abstract

Heterocyclic aromatic amines (HAAs), formed during the cooking of foods, are known to induce tumours in rodent bioassays and may thus contribute to human cancer risk. We tested six HAAs in a morphological transformation assay and in three in vitro genotoxicity assays. The morphological transforming abilities of HAAs were tested, in the presence of rat-liver S9, in the C3H/M2 fibroblast cell line. Concentration levels of 50 microM 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (8-MeIQx), 100 microM 2-amino-3,4,8-trimethylimidazo-[4,5-f]quinoxaline (4,8-DiMeIQx), 50 microM 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 100 microM 2-amino-9H-pyrido[2,3-b]indole (AalphaC), 100 microM 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAalphaC) and 15 microM 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced maximum transformation potencies of 5.5, 6.6, 6.3, 5.2, 7.3 and 9.2 transformed foci per 10(4) surviving cells, respectively. Bacterial mutagenic activity was determined in the presence of rat-liver S9 using the Salmonella typhimurium reverse-mutation assay employing strain YG1019. Mutagenic potencies of 3800 revertants (revs)/ng with 8-MeIQx, 2900 revs/ng with 4,8-DiMeIQx, 3480 revs/ng with IQ, 1.6 revs/ng with AalphaC, 2.9 revs/ng with MeAalphaC and 5 revs/ng with PhIP were observed. Clastogenic activity in vitro was analysed by the micronucleus assay in metabolically competent MCL-5 cells. Dose-dependent induction of micronuclei was observed for all HAAs tested with 1-5.4% of cells containing micronuclei at 10 ng/ml. Micronucleus induction was in the order 4,8-DiMeIQx > 8-MeIQx > IQ > MeAalphaC > PhIP > AalphaC. DNA strand-breaking activity in MCL-5 cells was measured by the alkaline single cell-gel (comet) assay. The lowest effect doses for significant increases (P < or = 0.0007, Mann-Whitney test) in comet tail length (microm) were 45.5 microg/ml (200 microM) for PhIP, 90.9 microg/ml (410-510 microM) for 4,8-DiMeIQx, IQ, MeAalphaC and AalphaC, and 454.5 microg/ml (2130 microM) for 8-MeIQx. It is not yet clear which of these assays most accurately reflects the genotoxic potential to humans of compounds of this class of environmental carcinogens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223180     DOI: 10.1093/carcin/20.4.545

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  Carcinogen-specific induction of genetic instability.

Authors:  A Bardelli; D P Cahill; G Lederer; M R Speicher; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Quantification of Hemoglobin and White Blood Cell DNA Adducts of the Tobacco Carcinogens 2-Amino-9H-pyrido[2,3-b]indole and 4-Aminobiphenyl Formed in Humans by Nanoflow Liquid Chromatography/Ion Trap Multistage Mass Spectrometry.

Authors:  Tingting Cai; Medjda Bellamri; Xun Ming; Woon-Puay Koh; Mimi C Yu; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2017-05-25       Impact factor: 3.739

3.  Metabolism of the Tobacco Carcinogen 2-Amino-9H-pyrido[2,3-b]indole (AαC) in Primary Human Hepatocytes.

Authors:  Medjda Bellamri; Ludovic Le Hegarat; Robert J Turesky; Sophie Langouët
Journal:  Chem Res Toxicol       Date:  2016-12-15       Impact factor: 3.739

4.  Sensitive quantitative assay for point mutations in the rat H-ras gene based on single nucleotide primer extension.

Authors:  Yoshihisa Yano; Tomohiro Yano; Anna Kinoshita; Ai Matoba; Tadayoshi Hasuma; Hideki Wanibuchi; Keiichirou Morimura; Shuzo Otani; Shoji Fukushima
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

5.  Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.

Authors:  Angela K Goodenough; Herman A J Schut; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2007-02       Impact factor: 3.739

6.  Is the comet assay a sensitive procedure for detecting genotoxicity?

Authors:  Satomi Kawaguchi; Takanori Nakamura; Ayumi Yamamoto; Gisho Honda; Yu F Sasaki
Journal:  J Nucleic Acids       Date:  2010-11-01

7.  Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.

Authors:  Lindsay M Morton; Sophia S Wang; Wendy Cozen; Martha S Linet; Nilanjan Chatterjee; Scott Davis; Richard K Severson; Joanne S Colt; Mohammad A Vasef; Nathaniel Rothman; Aaron Blair; Leslie Bernstein; Amanda J Cross; Anneclaire J De Roos; Eric A Engels; David W Hein; Deirdre A Hill; Linda E Kelemen; Unhee Lim; Charles F Lynch; Maryjean Schenk; Sholom Wacholder; Mary H Ward; Shelia Hoar Zahm; Stephen J Chanock; James R Cerhan; Patricia Hartge
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

8.  DNA adducts of the tobacco carcinogens 2-amino-9H-pyrido[2,3-b]indole and 4-aminobiphenyl are formed at environmental exposure levels and persist in human hepatocytes.

Authors:  Gwendoline Nauwelaërs; Medjda Bellamri; Valérie Fessard; Robert J Turesky; Sophie Langouët
Journal:  Chem Res Toxicol       Date:  2013-08-16       Impact factor: 3.739

9.  Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.

Authors:  Amit D Joshi; Román Corral; Kimberly D Siegmund; Robert W Haile; Loïc Le Marchand; Maria Elena Martínez; Dennis J Ahnen; Robert S Sandler; Peter Lance; Mariana C Stern
Journal:  Carcinogenesis       Date:  2008-11-24       Impact factor: 4.944

10.  Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.

Authors:  Kaarthik John; Narasimhan Ragavan; M Margaret Pratt; Paras B Singh; Salah Al-Buheissi; Shyam S Matanhelia; David H Phillips; Miriam C Poirier; Francis L Martin
Journal:  Prostate       Date:  2009-04-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.